An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia
Completed
- Conditions
- Anemia
- Registration Number
- NCT01105494
- Lead Sponsor
- Hoffmann-La Roche
- Brief Summary
This multicenter, prospective, observational study will evaluate the quality of life and the factors that influence the quality of life of epoetin beta \[Neorecormon\] in patients with renal chronic anemia, who are on dialysis. For each eligible patient data will be collected for 6 months. Target sample size is 5000-7000 patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6000
Inclusion Criteria
- Adult patients >/=18 years of age
- Dialysis patients with chronic renal anemia
- Written informed consent
Read More
Exclusion Criteria
- Red blood cell transfusion in the previous 2 months
- Severe neuropsychological disorder
- Diabetic patients with serious complications
This trial is being conducted in Morocco.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life assessment: Kidney Disease Quality of Life Questionnaire Throughout study: 6 months
- Secondary Outcome Measures
Name Time Method Evaluation of factors (demographic and social characteristics, dialysis method) influencing the quality of life Throughout study: 6 months